Page last updated: 2024-10-30

mebendazole and Central Nervous System Cysticercosis

mebendazole has been researched along with Central Nervous System Cysticercosis in 1 studies

Mebendazole: A benzimidazole that acts by interfering with CARBOHYDRATE METABOLISM and inhibiting polymerization of MICROTUBULES.
mebendazole : A carbamate ester that is methyl 1H-benzimidazol-2-ylcarbamate substituted by a benzoyl group at position 5.

Research Excerpts

ExcerptRelevanceReference
"The current pharmacological treatment of neurocysticercosis is based on two drugs, praziquantel (PZQ) and albendazole; however, suboptimal efficacy has been documented."3.96Cysticidal activity of praziquantel-mebendazole combination: In vitro and in vivo studies. ( Fernanda, GM; Francisca, PA; Guadalupe, PH; Helgi, JC; Iliana, GH; Javier, LF; Nelly, C; Susana, RI, 2020)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Francisca, PA1
Javier, LF1
Guadalupe, PH1
Fernanda, GM1
Nelly, C1
Helgi, JC1
Iliana, GH1
Susana, RI1

Other Studies

1 other study available for mebendazole and Central Nervous System Cysticercosis

ArticleYear
Cysticidal activity of praziquantel-mebendazole combination: In vitro and in vivo studies.
    Acta tropica, 2020, Volume: 202

    Topics: Albendazole; Animals; Anthelmintics; Blood-Brain Barrier; Cysticercosis; Drug Combinations; Mebendaz

2020